Skip to content

Agilon Health AGL Equity Method Liabilities

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept agl:EquityMethodLiabilities.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's equity method liabilities.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's equity method liabilities?
Agilon Health (AGL) reported equity method liabilities of $12.78M in Q1 2026.
How has Agilon Health's equity method liabilities changed year-over-year?
Agilon Health's equity method liabilities increased by 17.3% year-over-year, from $10.9M to $12.78M.
What is the long-term trend for Agilon Health's equity method liabilities?
Over 3 years (2022 to 2025), Agilon Health's equity method liabilities has grown at a 37.7% compound annual growth rate (CAGR), from $4.66M to $12.16M.